Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Next Previous
X
Search
Trial Profile

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Busulfan (Primary) ; Clofarabine (Primary) ; Cyclophosphamide (Primary) ; Cytarabine (Primary) ; Lymphokine-activated killer cells (Primary) ; Mycophenolate mofetil (Primary) ; Plerixafor (Primary) ; Tacrolimus (Primary)
  • Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Hodgkin's disease; Juvenile myelomonocytic leukaemia; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 May 2022 Results published in the Transplantation and Cellular Therapy
    • 21 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.
    • 21 Aug 2012 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top